NCT00092833终止3 期
An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 49
- 主要终点
- Incidence of clinical and laboratory adverse experiences in in patients with homozygous FH or homozygous sitosterolemia taking ezetimibe 10 mg/day
研究概览
简要总结
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 8 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Homozygous familial hypercholesterolemia or sitosterolemia
排除标准
- •Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study
结局指标
主要结局
Incidence of clinical and laboratory adverse experiences in in patients with homozygous FH or homozygous sitosterolemia taking ezetimibe 10 mg/day
时间窗: 3 years
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21H. Pylori InfectionNCT06045494Meiji China Investment Co.,Ltd140
已完成
1 期
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy SubjectsIdiopathic Pulmonary FibrosisNCT06135363Guangzhou JOYO Pharma Co., Ltd45
已完成
2 期
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)Nonalcoholic SteatohepatitisNCT03987074Gilead Sciences109
已完成
1 期
Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia ACongenital Bleeding DisorderHaemophilia ANCT02941354Novo Nordisk A/S35
已完成
3 期
Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple SclerosisMultiple SclerosisNCT00370071Bayer39